Booth No.5N-12
CategoryOutsourcing
Dr. Reddy's Laboratories Ltd.
Booth No.：5N-12
Category：Outsourcing
Company Information
Email：
api@drreddys.com
TEL：
Address： 500034
8-2-377, Road, No.3, Banjara Hills, Hyderabad INDIA URL： http://api.drreddys.com
8-2-377, Road, No.3, Banjara Hills, Hyderabad INDIA URL： http://api.drreddys.com
Contact in Japan
Japan agent： Dr Reddys Laboratories Japan
Email：
api@drreddys.com
TEL： +81-90-2590-0206
Address： 5-1, NIHOMBASHIKABUTOCHO KABUTOCHO NO.1 HEIWA BLDG. 3F. CHUO-KU, TOKYO,
With a portfolio of more than 200 commercially available APIs, Dr. Reddy’s API unit caters to leading innovator and generic companies across the US, Europe, Latin America, Japan, Korea and other emerging markets. With deep technical strengths in the development of complex APIs such as steroids, peptides, complex long chain and highly potent molecules we consistently deliver high-quality APIs and formulations. For more information log on to: www.api.drreddys.com.
Company information
| Address | 500034 8-2-377, Road, No.3, Banjara Hills, Hyderabad INDIA |
|---|---|
| URL | http://api.drreddys.com |
| api@drreddys.com |
| Product introduction |
APALUTAMIDE APIXABAN APREMILAST DABIGATRAN DAPAGLIFLOZIN EMPAGLIFLOZIN ENZALUTAMIDE LENVATINIB LINAGLIPTIN LUBIPROSTONE MIRABEGRON MONTELUKAST NILOTINIB PALBOCICLIB Relugolix SITAGLIPTIN SUGAMMADEX Tafamidis TOFACITINIB VENETOCLAX |
|---|
Contact in Japan
| Japan Agent | Dr Reddys Laboratories Japan |
|---|---|
| Address | 5-1, NIHOMBASHIKABUTOCHO KABUTOCHO NO.1 HEIWA BLDG. 3F. CHUO-KU, TOKYO, |
| TEL | +81-90-2590-0206 |
| api@drreddys.com |
Product introduction
APALUTAMIDEAPIXABANAPREMILAST DABIGATRANDAPAGLIFLOZINEMPAGLIFLOZIN ENZALUTAMIDELENVATINIBLINAGLIPTIN LUBIPROSTONEMIRABEGRONMONTELUKASTNILOTINIBPALBOCICLIBRelugolixSITAGLIPTIN SUGAMMADEXTafamidis TOFACITINIB VENETOCLAX New Technology Seminar
〈Free of charge〉 Same day registration
If you would like to attend, please come directly to the seminar venue.
April 10(Thu.) 11:30 - 12:00 【6B】
The Role of ESG Standards in Robust API and Formulation Supply